Barclays lowered the firm’s price target on Novonesis (NVZMY) to DKK 500 from DKK 525 and keeps an Overweight rating on the shares.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter